Other languages Venus Medtech (Hangzhou) Inc.

Equities

2500

CNE100003PJ8

Market Closed - Hong Kong S.E. Other stock markets 08:08:30 22/11/2023 GMT			5-day change	1st Jan Change
5.62 ^HKD	-0.71%		-.--%	-.--%

06-14	Venus Medtech Venusp-Valve Completes First Implantation in Ide Pivotal Clinical Study in U.S	CI
06-14	Venus Medtech (Hangzhou) Implants First Patient with VenusP-Valve in US Clinical Study	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Venus Medtech Venusp-Valve Completes First Implantation in Ide Pivotal Clinical Study in U.S	06-14
Venus Medtech (Hangzhou) Implants First Patient with VenusP-Valve in US Clinical Study	06-14
Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21%	04-01
Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Venus Medtech Inc. Announces That Wan Yee Joseph Lau, an Independent Non-Executive Director, the Chairman of the Nomination Committee and A Member of Each of the Remuneration and Assessment Committee and the Audit Committee of the Board, Passed Away	02-07
Venus Medtech Inc. Approves Mr. Liqiao Ma as an Executive Director	12-15
Venus Medtech Inc. Announces Executive Changes	11-20
Venus Medtech Inc. Announces Appointment of Mr. Lim Housen (Lin Haosheng) as Joint Chief Executive Officer with Effect from September 22, 2023	22/09/23
Venus Medtech's H1 Attributable Loss Widens	01/09/23
Venus Medtech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Venus Medtech Inc. Announces it's Self-Developed Transcatheter Pulmonary Valve Replacement System VenusP-Valve Received the Approval of IDE (Investigational Device Exemption) Application from the US Food and Drug Administration	06/08/23
Venus Medtech Inc. Announces Resignation of Haiyue Ma as Joint Company Secretary	02/06/23
Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
Venus Medtech Inc. Announces Completion of Full Patient Enrollment for Confirmatory Clinical Trial of Liwen RF in China	03/03/23
Venus Medtech Inc. Announces Board Changes	30/01/23
Venus Medtech Inc. Announces Resignation of Lim Hou-Sen as an Executive Director and Nisa Bernice Wing-Yu Leung as Non-Executive Director and Vice Chairwoman	13/12/22
Venus Medtech (Hangzhou)'s H1 Loss Widens 76.8%	01/09/22
Venus Medtech Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22
Venus Medtech Inc. Announces Change of Employee Representative Supervisor and Chairperson of the Supervisory Committee	31/08/22
China's National Medical Products Administration Approves Venusp-Valve, Venus Medtech's In-House Developed Innovative Transcatheter Pulmonic Valve Replacement System	13/07/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Venus Medtech (Hangzhou) Inc.

Equities

2500

CNE100003PJ8

Other languages

Filters